Researchers investigate the underlying mechanisms of endothelial insulin resistance involved in obesity-associated diabetes.

Researchers have discovered a new mechanism that is used by a male sex hormone essential for muscle and bone function. The ...

Researchers at Leipzig University’s Faculty of Medicine and Shandong University in China have discovered a new mechanism that ...

Adrenomedullin (ADM) inhibits endothelial insulin signaling, contributing to obesity-associated insulin resistance, according ...

Melio Bio, a biotech dedicated to the discovery and development of novel inhibitors targeting a receptor implicated in obesity and associated co-morbidities, has been revealed as the winner of Pioneer ...

Bayer is committed to advancing treatment in prostate cancer care, showcasing new analyses from its comprehensive clinical trial program for NUBEQA ® (darolutamide), which includes the ARANOTE, ...

An innovative organoid model mirrors the pancreas' complexity, generating all three key cell types to explore development and ...

Cantor Fitzgerald reaffirmed its Overweight rating on Septerna Inc (NASDAQ:SEPN) with a price target of $50.00, representing significant upside from the current price of $13.17. The firm's analysis ...

The table below is a review of notable updates that occurred in January 2025 for investigational products in development.

A new study in an animal model provides direct evidence for the role of the vagus nerve in gut microbiome-brain communication, addressing a critical gap in the field.

Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25If approved, FILSPARI ...

Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25 If approved, FILSPARI could be the first and only approved medicine indicated ...